Drug Shortage Report for INDIUM DTPA IN 111

Last updated on 2020-05-19 History
Report ID 104510
Drug Identification Number 02329093
Brand name INDIUM DTPA IN 111
Common or Proper name Pentetate Indium Disodium In 111
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) PENTETATE INDIUM DISODIUM IN 111
Strength(s) 37MBq
Dosage form(s) SOLUTION
Route of administration INTRATHECAL
Packaging size 1.5 mL
ATC code V09AX
ATC description
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2020-06-17
Actual start date
Estimated end date 2020-07-16
Actual end date 2020-05-19
Shortage status Avoided shortage
Updated date 2020-05-19
Company comments
Health Canada comments
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2020-05-19 French Compare
v8 2020-05-19 English Compare
v7 2020-01-29 French Compare
v6 2020-01-29 English Compare
v5 2020-01-29 French Compare
v4 2020-01-29 English Compare
v3 2020-01-29 English Compare
v2 2020-01-29 English Compare
v1 2020-01-28 English Compare